tickerreport.com
Positivewww.tickerreport.com Β·
silo pharma silo projected to post quarterly earnings on friday
ECON_ENTREPRENEURSHIPTAX_FNCACT_ANALYSTWB_1331_HEALTH_TECHNOLOGIESWB_2453_ORGANIZED_CRIME
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedSilo Pharma is a small-cap biotech company. The earnings release is a routine quarterly event with no disclosed commercial mechanism, product pipeline update, or regulatory catalyst. Impact is limited to the company's stock price and is not sector-wide.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources β not direct quotes from the publisher.
- Silo Pharma to report Q1 2026 earnings on May 8, 2026.
- Analysts estimate EPS loss of $0.32 and revenue of $0.018 million.
- Previous quarter EPS was $0.03 on revenue of $0.02 million.
- Stock price $0.45, market cap $7.34 million.
- Institutional ownership 5.58%.